InvestorsHub Logo
Followers 2
Posts 188
Boards Moderated 0
Alias Born 01/09/2019

Re: dcaf7 post# 309

Friday, 03/24/2023 1:59:48 PM

Friday, March 24, 2023 1:59:48 PM

Post# of 572
That's my point. The design and targets will be negotiated. Sounds like they want to include an interim analysis for fast approval if data warrants. We need to wait until after they meet with the FDA on this. I don't expect an FDA meeting regarding combinations until late this year or early next year.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APTO News